These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9476504)

  • 21. [Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
    Burgaleta C
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():31-7. PubMed ID: 9441303
    [No Abstract]   [Full Text] [Related]  

  • 22. Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis.
    Shorr AF; Chung K; Jackson WL; Waterman PE; Kollef MH
    Crit Care Med; 2005 Sep; 33(9):1928-35; quiz 1936. PubMed ID: 16148461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antifungal agents for preventing fungal infections in solid organ transplant recipients.
    Playford EG; Webster AC; Sorell TC; Craig JC
    Cochrane Database Syst Rev; 2004; (3):CD004291. PubMed ID: 15266524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nystatin prophylaxis and treatment in severely immunodepressed patients.
    Gøtzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD002033. PubMed ID: 25188770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.
    Ullmann AJ; Lipton JH; Vesole DH; Chandrasekar P; Langston A; Tarantolo SR; Greinix H; Morais de Azevedo W; Reddy V; Boparai N; Pedicone L; Patino H; Durrant S
    N Engl J Med; 2007 Jan; 356(4):335-47. PubMed ID: 17251530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluconazole in children: first experience with prophylaxis in chemotherapy-induced neutropenia in pediatric patients with cancer.
    Cáp J; Mojzesova A; Kayserova E; Bubánska E; Hatiar K; Trupl J; Krcméry V
    Chemotherapy; 1993; 39(6):438-42. PubMed ID: 8222873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic fungal infections: major problems in cancer patients.
    Powles RL; Mehta J
    Indian J Cancer; 1994 Sep; 31(3):180-4. PubMed ID: 8557296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal prophylaxis in adult hematopoietic stem cell transplant recipients.
    Tamura K; Drew R
    Drugs Today (Barc); 2008 Jul; 44(7):515-30. PubMed ID: 18806902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylaxis, empirical therapy, or pre-emptive therapy of fungal infections in immunocompromised patients: which is better for whom?
    Leather HL; Wingard JR
    Curr Opin Infect Dis; 2002 Aug; 15(4):369-75. PubMed ID: 12130932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis. An autopsy study of 355 patients.
    van Burik JH; Leisenring W; Myerson D; Hackman RC; Shulman HM; Sale GE; Bowden RA; McDonald GB
    Medicine (Baltimore); 1998 Jul; 77(4):246-54. PubMed ID: 9715729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical aspects of fungal infection in organ transplant recipients.
    Hibberd PL; Rubin RH
    Clin Infect Dis; 1994 Aug; 19 Suppl 1():S33-40. PubMed ID: 7948569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fungal infections in patients undergoing blood and marrow transplantation.
    Marr KA; Bowden RA
    Transpl Infect Dis; 1999 Dec; 1(4):237-46. PubMed ID: 11428995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylaxis against fungal infections and cytomegalovirus disease after bone marrow transplantation.
    Wilkin A; Feinberg J
    Oncology (Williston Park); 2000 Dec; 14(12):1701-8; discussion 1708, passim. PubMed ID: 11212856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials.
    Vardakas KZ; Michalopoulos A; Falagas ME
    Br J Haematol; 2005 Oct; 131(1):22-8. PubMed ID: 16173959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of fungal and other opportunistic infections in immunocompromised patients.
    Wade JC
    Leukemia; 1997 May; 11 Suppl 4():S38-9. PubMed ID: 9179282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fungal infections in transplantation patients].
    Colomba C; Antinori S
    Recenti Prog Med; 2003 Nov; 94(11):516-28. PubMed ID: 14679922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
    Goodman JL; Winston DJ; Greenfield RA; Chandrasekar PH; Fox B; Kaizer H; Shadduck RK; Shea TC; Stiff P; Friedman DJ
    N Engl J Med; 1992 Mar; 326(13):845-51. PubMed ID: 1542320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Azole antifungal agents in the prevention of fungal infections in neutropenic patients and bone marrow graft recipients].
    Lortholary O; Dupont B
    Ann Med Interne (Paris); 1997; 148(3):258-67. PubMed ID: 9255336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal chemoprophylaxis after blood and marrow transplantation.
    Wingard JR
    Clin Infect Dis; 2002 May; 34(10):1386-90. PubMed ID: 11981735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal prophylaxis with weekly fluconazole for patients with AIDS.
    Mylonakis E; Flanigan TP
    Clin Infect Dis; 1998 Dec; 27(6):1376-8. PubMed ID: 9868645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.